Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rosemarie Walsh
Observed names:
R Walsh,
R. Walsh
Institution:
Incannex Healthcare Inc. (Australia)
Observed institution:
Incannex Healthcare Inc. (Australia)
ORCID:
0009-0009-6264-8973
Observed ORCID:
0009-0009-6264-8973
OpenAlex ID:
A5017081637
The impact of acetazolamide and dronabinol on the physiological endotypes responsible for obstructive sleep apnea
2025
·
Luke D.J. Thomson
, Shane A. Landry
, et al.
·
Sleep Medicine
·
9
A randomized dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnea
2024
·
Jennifer Walsh
, Timothy Rankin
, et al.
·
SLEEP
·
9
An open-label phase I comparator-controlled clinical trial to assess tolerability and pharmacokinetics of IHL-675 A a fixed dose combination of cannabidiol plus hydroxychloroquine in healthy volunteers
2025
·
George Williams Mbogo
, Pia Kroner
, et al.
·
Scientific Reports
·
3
PDF
0451 Dronabinol Plus Acetazolamide for the Treatment of Obstructive Sleep Apnoea: A Proof of Concept and Mechanistic Exploration Study
2023
·
Luke Thomson
, Timothy Rankin
, et al.
·
SLEEP
·
1
PDF
A Randomised Controlled Trial Examining the Combined Impact of Acetazolamide and Dronabinol for the Treatment of Obstructive Sleep Apnoea
2023
·
L.D.J. Thomson
, T. Rankin
, et al.
·
American Journal of Respiratory and Critical Care Medicine
O027 A randomised dose finding study of combination dronabinol and acetazolamide for the treatment of obstructive sleep apnoea: A proof of concept study
2022
·
J Walsh
, T Rankin
, et al.
·
SLEEP Advances
PDF
Show more works
View as search
Works count:
6
Citation count:
22
H-index:
3
I10-index:
Year
Topic
Type